Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

Bill 115 HR 2410, also known as the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017, is a piece of legislation aimed at addressing the challenges faced by individuals with sickle cell disease. The bill was introduced in the House of Representatives on May 11, 2017, by Rep. Danny Davis of Illinois.

The main goals of the bill are to improve research efforts related to sickle cell disease, enhance surveillance and monitoring of the disease, and promote prevention and treatment strategies. The bill seeks to increase funding for research on sickle cell disease, with a focus on developing new treatments and improving outcomes for individuals with the disease.

Additionally, the bill aims to improve surveillance and monitoring of sickle cell disease by establishing a national surveillance system to track the prevalence of the disease and its impact on individuals and communities. This data will help inform public health efforts and guide resource allocation for prevention and treatment programs. The bill also includes provisions to promote education and awareness about sickle cell disease, as well as to support efforts to improve access to care for individuals with the disease. This includes funding for community-based programs and initiatives to increase awareness and understanding of sickle cell disease among healthcare providers and the general public. Overall, Bill 115 HR 2410 represents a comprehensive approach to addressing the challenges faced by individuals with sickle cell disease. By increasing research funding, improving surveillance and monitoring efforts, and promoting prevention and treatment strategies, the bill aims to improve outcomes and quality of life for individuals with sickle cell disease.